Phalaris minor pollen

Identification

Name
Phalaris minor pollen
Accession Number
DB10963
Description

Phalaris minor pollen is the pollen of the Phalaris minor plant. Phalaris minor pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • littleseed canary grass pollen extract

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololThe risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Acebutolol.
AtenololThe risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Atenolol.
BenazeprilThe risk or severity of adverse effects can be increased when Benazepril is combined with Phalaris minor pollen.
BetaxololThe risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Betaxolol.
BisoprololThe risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Bisoprolol.
CaptoprilThe risk or severity of adverse effects can be increased when Captopril is combined with Phalaris minor pollen.
CarvedilolThe risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Carvedilol.
CeliprololThe risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Celiprolol.
CilazaprilThe risk or severity of adverse effects can be increased when Cilazapril is combined with Phalaris minor pollen.
EnalaprilThe risk or severity of adverse effects can be increased when Enalapril is combined with Phalaris minor pollen.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Canary Grass PollenInjection, solution1 g/20mLPercutaneous; SubcutaneousAllergy Laboratories, Inc.1967-12-07Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
VBT3DRA2R9
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347911052
RxNav
1098232

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionPercutaneous; Subcutaneous1 g/20mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 13:04 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates